Photonz Corporation Overview

  • Founded
  • 2002
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Photonz Corporation General Information

Description

Operator of a biotechnology company intended to address cardiovascular diseases. The company produces omega-3 fatty acid eicosapentaenoic acid (EPA) from its primary source, marine microalgae using proprietary fermentation technology, thereby providing pharmaceutical companies the critical ingredient required in medicinal foods and pharmaceutical products.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Primary Office
  • P.O. Box 21219
  • Henderson
  • Auckland, 0650
  • New Zealand
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Photonz Corporation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2018 00.000 Completed Out of Business
3. Angel (individual) 01-Aug-2011 00.000 Completed Startup
2. Grant 28-Mar-2011 $2.15M $2.19M Completed Startup
1. Early Stage VC $2.19M $2.19M Completed Startup
To view Photonz Corporation’s complete valuation and funding history, request access »

Photonz Corporation Patents

Photonz Corporation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130273637-A1 Method of provision of silicate to culture media Abandoned 22-Oct-2010 00000000
AU-2011318683-A1 Method of provision of silicate to culture media Abandoned 22-Oct-2010 00000000
EP-2629882-A1 Method of provision of silicate to culture media Withdrawn 22-Oct-2010 00000000
AU-2011312987-A1 Heterotrophic microbial production of xanthophyll pigments Abandoned 06-Oct-2010 000000000
US-20130309719-A1 Heterotrophic microbial production of xanthophyll pigments Abandoned 06-Oct-2010 C12P23/00 0